Semax
ACTH 4-10 analogue. Studied for BDNF/NGF production, dopamine/serotonin modulation, and synaptic plasticity.
Index entry
Research context
ACTH 4-10 analogue. Studied for BDNF/NGF production, dopamine/serotonin modulation, and synaptic plasticity.
How to read this entry
The current evidence grade is Phase II. It describes the strongest verified research stage represented in the record; it is not a statement of safety, efficacy or suitability for use.
Editorial scope
This entry is an evidence index, not medical guidance. Detailed mechanisms, open questions and primary references can be added through the structured editorial importer as the record is reviewed.